Suven Life Sciences Limited (BSE: 530239)
Health Care · Life Sciences Tools & Services · IN
Rs282.75
-8.35% today · +35.1% 1Y
Suven Life Sciences Limited (BSE: 530239) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $825.52M.
Over the last twelve months the share price has gained 35.1%, trading between 124.35 and 402.90.
Tweenvest scores Suven Life Sciences Limited across four factors: quality 37/100, value 56/100, growth 0/100. Its strongest factor is value.
530239 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $825.52M
- Revenue (TTM)
- $932.17K
- P/E
- —
- EPS
- -14.74
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- Rs402.90
- 52-week low
- Rs124.35
- Avg volume (3M)
- —
- Shares outstanding
- 282.56M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| R&G PharmaStudies Co., Ltd.SZSE: 301333 | $887.87M | CN¥62.08 | -6.88% |
| Cryoport, Inc.NasdaqCM: CYRX | $878.76M | $16.96 | -2.25% |
| Ginkgo Bioworks Holdings, Inc.NYSE: DNA | $875.42M | $11.61 | -10.69% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $864.83M | CN¥9.58 | +0.52% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $807.40M | CN¥8.58 | -3.05% |
| Boji Medical Technology Co.,Ltd.SZSE: 300404 | $806.99M | CN¥14.11 | -4.21% |
| Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.SZSE: 301096 | $739.13M | CN¥45.65 | -7.40% |
| Pacific Biosciences of California, Inc.NasdaqGS: PACB | $724.24M | $2.14 | -8.37% |
Figures last refreshed Oct 11, 2026.